Correlation Between Dermata Therapeutics and Seres Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics and Seres Therapeutics, you can compare the effects of market volatilities on Dermata Therapeutics and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and Seres Therapeutics.
Diversification Opportunities for Dermata Therapeutics and Seres Therapeutics
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Dermata and Seres is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and Seres Therapeutics go up and down completely randomly.
Pair Corralation between Dermata Therapeutics and Seres Therapeutics
Given the investment horizon of 90 days Dermata Therapeutics is expected to generate 3.4 times less return on investment than Seres Therapeutics. But when comparing it to its historical volatility, Dermata Therapeutics is 1.84 times less risky than Seres Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Seres Therapeutics is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 81.00 in Seres Therapeutics on September 4, 2024 and sell it today you would earn a total of 12.00 from holding Seres Therapeutics or generate 14.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dermata Therapeutics vs. Seres Therapeutics
Performance |
| Timeline |
| Dermata Therapeutics |
| Seres Therapeutics |
Dermata Therapeutics and Seres Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dermata Therapeutics and Seres Therapeutics
The main advantage of trading using opposite Dermata Therapeutics and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.| Dermata Therapeutics vs. Candel Therapeutics | Dermata Therapeutics vs. Cingulate Warrants | Dermata Therapeutics vs. Unicycive Therapeutics | Dermata Therapeutics vs. Quoin Pharmaceuticals Ltd |
| Seres Therapeutics vs. Candel Therapeutics | Seres Therapeutics vs. Cingulate Warrants | Seres Therapeutics vs. Unicycive Therapeutics | Seres Therapeutics vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |